Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors

ABSTRACT: RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combining irinotecan and gemcitabine in treating patients who have unresectable or metastatic solid tumors.

DISEASE(S): Kidney Neoplasms,Lung Cancer,Colorectal Cancer,Urinary Bladder Neoplasms,Bladder Cancer,Pancreatic Cancer,Breast Neoplasms,Pancreatic Neoplasms,Kidney Cancer,Lung Neoplasms,Breast Cancer

PROVIDER: 2003528 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR